Home › Companies › LIGAND PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and LIGAND PHARMACEUTICALS INC.’s Form 8-K, filed 2024-06-17 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore LIGAND PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are LIGAND PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-17 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jason M. Aryeh | 12,265,786 | -- | -- | 3,259,850 | 1,154,516 | Majority: yes |
| Elect Director: Todd C. Davis | 15,244,447 | -- | -- | 281,189 | 1,154,516 | Majority: yes |
| Elect Director: Nancy R. Gray, Ph.D. | 14,876,443 | -- | -- | 649,193 | 1,154,516 | Majority: yes |
| Elect Director: Jason Haas | 15,284,373 | -- | -- | 241,263 | 1,154,516 | Majority: yes |
| Elect Director: John W. Kozarich, Ph.D. | 14,024,170 | -- | -- | 1,501,466 | 1,154,516 | Majority: yes |
| Elect Director: John L. LaMattina, Ph.D. | 14,981,023 | -- | -- | 544,613 | 1,154,516 | Majority: yes |
| Elect Director: Stephen L. Sabba, M.D. | 14,839,776 | -- | -- | 685,860 | 1,154,516 | Majority: yes |
| Elect Director: Martine Zimmermann, Pharm.D. | 15,067,611 | -- | -- | 458,025 | 1,154,516 | Majority: yes |
| Proposal 3 . The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. In accordance with the results below, the proposal was approved. | 14,264,205 | 1,253,085 | 8,346 | -- | 1,154,516 | Majority: yes |
| Proposal 4 . The approval of the Restated Plan. In accordance with the results below, the proposal was approved. | 9,926,628 | 5,577,590 | 21,418 | -- | 1,154,516 | Majority: yes |
Source: LIGAND PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-06-17 — read the filing on EDGAR.
Each item below shows how the 299 asset managers that disclosed a LIGAND PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of LIGAND PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 10 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3 . The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. In accordance with the results below, the proposal was approved.”): 14,264,205 for, 1,253,085 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 17,924,000 outstanding shares: 80% for, 7% against (87% of the company cast a for/against vote).
The 296 asset managers below cast 91% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,299,092 | 0 | 0 | 0 | For |
| BlackRock | 2,059,973 | 5,101 | 0 | 0 | For |
| Janus Henderson | 975,601 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| State Street | 898,907 | 338 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 883,700 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 622,721 | 0 | 0 | 0 | For |
| CONGRESS ASSET MANAGEMENT CO /MA | 514,433 | 0 | 0 | 0 | For |
| Stephens Investment Management Group LLC | 508,005 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 468,510 | 0 | 0 | Against |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| VILLERE ST DENIS J & CO LLC | 417,364 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 368,617 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 356,671 | 0 | 0 | 0 | For |
| Fidelity | 341,977 | 0 | 0 | 0 | For |
| Charles Schwab | 295,021 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| SEI | 235,447 | 11,667 | 0 | 0 | For |
| DWS | 230,283 | 0 | 0 | 0 | For |
| ASHFORD CAPITAL MANAGEMENT INC | 226,285 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 3,402 | 218,605 | 0 | 0 | Against |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 218,421 | 0 | 0 | 0 | For |
| Invesco | 0 | 212,833 | 0 | 0 | Against |
| Northern Trust | 160,194 | 11 | 0 | 0 | For |
Showing the 25 largest of 296 asset managers. See all 296 in the interactive database.
Combines 5 wordings of this item as funds reported it.
66% fund support · no official result
The 95 asset managers below cast 66% of the shares they voted on this item FOR (6,270,582 for, 3,204,714 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,940,794 | 325,961 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 737,642 | 0 | 0 | Against |
| Dimensional | 0 | 562,595 | 0 | 0 | Against |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 243 | 287,103 | 0 | 0 | Against |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 0 | 230,218 | 0 | 0 | Against |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 104,221 | 0 | 0 | Against |
| Invesco | 0 | 103,295 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 98,553 | 0 | 0 | Against |
| Bridge Builder Trust | 6,397 | 87,553 | 0 | 0 | Against |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 66,487 | 0 | 0 | Against |
| Allspring | 0 | 66,485 | 0 | 0 | Against |
| WILLIAM BLAIR FUNDS | 0 | 60,340 | 0 | 0 | Against |
| Equitable | 25,727 | 21,289 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 0 | 45,194 | 0 | 0 | Against |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 0 | 39,282 | 0 | 0 | Against |
Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.8% fund support · no official result
The 92 asset managers below cast 99.8% of the shares they voted on this item FOR (9,477,854 for, 11,340 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,323 | 23 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,950 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jason Haas”): 15,284,373 for, 241,263 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 17,924,000 outstanding shares: 85% for, 1% withheld (87% of the company cast a for/withheld vote).
The 89 asset managers below cast 100% of the shares they voted on this item FOR (9,494,058 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,297 | 0 | 49 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,950 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 4 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jason M. Aryeh”): 12,265,786 for, 3,259,850 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 17,924,000 outstanding shares: 68% for, 18% withheld (87% of the company cast a for/withheld vote).
The 89 asset managers below cast 100% of the shares they voted on this item FOR (7,821,461 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 737,642 | 0 | Abstain |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 514 | 0 | 286,832 | 0 | Abstain |
| IMPAX FUNDS SERIES TRUST I | 0 | 0 | 255,208 | 0 | Abstain |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 107,525 | 0 | Abstain |
| Aberdeen | 0 | 0 | 104,221 | 0 | Abstain |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 10,031 | 0 | 56,456 | 0 | Abstain |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 42,665 | 0 | Abstain |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: John L. LaMattina, Ph.D.”): 14,981,023 for, 544,613 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 17,924,000 outstanding shares: 84% for, 3% withheld (87% of the company cast a for/withheld vote).
The 89 asset managers below cast 100% of the shares they voted on this item FOR (9,493,169 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,273 | 0 | 73 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 4 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: John W. Kozarich, Ph.D.”): 14,024,170 for, 1,501,466 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 17,924,000 outstanding shares: 78% for, 8% withheld (87% of the company cast a for/withheld vote).
The 89 asset managers below cast 100% of the shares they voted on this item FOR (9,099,749 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,234 | 0 | 112 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 0 | 0 | 255,208 | 0 | Abstain |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 104,221 | 0 | Abstain |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Martine Zimmermann, Pharm.D.”): 15,067,611 for, 458,025 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 17,924,000 outstanding shares: 84% for, 3% withheld (87% of the company cast a for/withheld vote).
The 89 asset managers below cast 100% of the shares they voted on this item FOR (9,470,183 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,346 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,950 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Nancy R. Gray, Ph.D.”): 14,876,443 for, 649,193 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 17,924,000 outstanding shares: 83% for, 4% withheld (87% of the company cast a for/withheld vote).
The 89 asset managers below cast 100% of the shares they voted on this item FOR (9,471,835 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,257 | 0 | 89 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Stephen L. Sabba, M.D.”): 14,839,776 for, 685,860 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 17,924,000 outstanding shares: 83% for, 4% withheld (87% of the company cast a for/withheld vote).
The 89 asset managers below cast 100% of the shares they voted on this item FOR (9,471,880 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,273 | 0 | 73 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 25,727 | 0 | 21,289 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Todd C. Davis”): 15,244,447 for, 281,189 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 17,924,000 outstanding shares: 85% for, 2% withheld (87% of the company cast a for/withheld vote).
The 89 asset managers below cast 100% of the shares they voted on this item FOR (9,493,348 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,273 | 0 | 73 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 4 asset managers below cast 100% of the shares they voted on this item FOR (9,724 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Jackson Creek Investment Advisors LLC | 4,968 | 0 | 0 | 0 | For |
| TIMOTHY PLAN | 3,975 | 0 | 0 | 0 | For |
| SYNTAX ETF TRUST | 761 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 20 | 0 | 0 | 0 | For |
75% fund support · no official result
The 2 asset managers below cast 75% of the shares they voted on this item FOR (36,564 for, 12,455 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Uniplan Investment Counsel, Inc. | 36,564 | 0 | 0 | 0 | For |
| Empower | 0 | 12,455 | 0 | 0 | Against |
Ranked by the number of LIGAND PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 17,924,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.83% |
| 2 | BlackRock | 11.52% |
| 3 | Janus Henderson | 5.44% |
| 4 | JANUS INVESTMENT FUND | 5.09% |
| 5 | State Street | 5.02% |
| 6 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 4.93% |
| 7 | Delaware/Macquarie | 4.12% |
| 8 | Dimensional | 3.47% |
| 9 | CONGRESS ASSET MANAGEMENT CO /MA | 2.87% |
| 10 | Stephens Investment Management Group LLC | 2.83% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 16.09% | 13F |
| Vanguard Group | 11.58% | 13F |
| Janus Henderson Group plc | 7.49% | DEF14A |
| Macquarie Group Limited | 5.51% | DEF14A |
| State Street | 3.75% | 13F |
| Dimensional Fund Advisors | 3.70% | 13F |
| FMR (Fidelity) | 2.55% | 13F |
| Geode Capital | 2.13% | 13F |
| Goldman Sachs | 2.05% | 13F |
| Matthew Korenberg | 1.36% | DEF14A |
Percentages above are of 17,924,000 shares outstanding, as reported by LIGAND PHARMACEUTICALS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LIGAND PHARMACEUTICALS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At LIGAND PHARMACEUTICALS INC.'s shareholder meeting held 2024-06-14, in the 2023-2024 proxy season, 299 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,640 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of the named executive officers — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: LIGAND PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-17.
LIGAND PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.